H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Prevention of Hepatitis B Recurrence after Liver Transplantation

Wojciech G Polak, Andrzej Gladysz, Katarzyna Rotter

Ann Transplant 2005; 10(3): 11-16

ID: 433649

Available online:

Published:


Over the last decade significant improvement in patient and graft survival has been observed after liver transplantation for hepatitis B virus
(HBV)-related liver disease, mostly because of efficient prophylaxis against hepatitis B reinfection. This review discusses different approches in prevention of hepatitis B recurrence in liver recipients including new concepts as vaccination against hepatitis B after liver transplantation. Based on available data combined prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine is currently recommended prophylaxis for HBV recurrence after liver transplantation.

Keywords: Liver Transplantation, Hepatitis B, Recurrence, prevention, Hepatitis B Immunoglobuline, Lamivudine, Adefovir, Vaccination



Back